Conventional strategy
Sponsors
Fundación para la Investigación del Hospital Clínico de Valencia, China National Center for Cardiovascular Diseases, University Hospital, Montpellier, Dong-A University, Guangzhou Red Cross Hospital
Conditions
Acute Myocardial InfarctionAtrial FibrillationCoronary Artery DiseaseDiastolic Heart FailureHeart FailureHemodynamicsKidney Disease
CardiologySystolic Heart Failure Stage C
Phase 1
Phase 4
Loop Diuretic Dosage in Patients With Acute Heart Failure and Renal Failure: Conventional Versus Carbohydrate Antigen 125-guided Therapy (IMPROVE-HF)
CompletedNCT02643147
Start: 2015-01-31End: 2017-01-30Updated: 2018-02-13
Ticagrelor De-escalation Strategy in AMI Patients
RecruitingNCT04755387
Start: 2023-03-27End: 2028-01-31Target: 2312Updated: 2025-10-01
Unknown Phase
Conventional Versus Intentional StraTegy in Lesions With High Risk PrEdiction of Side Branch OccLusion in InterVEntion
NCT02644434
Start: 2016-12-01End: 2020-12-01Target: 566Updated: 2019-01-11
ST2 for the Management of Heart Failure - STADE-HF
CompletedNCT02963272
Start: 2017-01-19End: 2019-04-26Updated: 2025-09-30
Study on the Effect of Capacity Shock Intervention Under Goal-directed Hemodynamic Management on P-V Loop
CompletedNCT04934761
Start: 2020-06-01End: 2021-06-10Updated: 2021-06-22
Substrate abLatIon as Concomitant trEatment for Left Atrial Macroreentrant Tachycardia
NCT05842499
Start: 2021-06-15End: 2026-01-01Target: 128Updated: 2023-07-11